ICICI Bank Ltd:企業のM&A・事業提携・投資動向

◆英語タイトル:ICICI Bank Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C1227
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:122
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

ICICI Bank Ltd – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s ICICI Bank Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by ICICI Bank Ltd since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes ICICI Bank Ltd’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by ICICI Bank Ltd. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on ICICI Bank Ltd’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by ICICI Bank Ltd and its subsidiaries since 2007.
- Information about key financial and legal advisors for ICICI Bank Ltd’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about ICICI Bank Ltd’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 7
LIST OF FIGURES 7
TARGETS AND PARTNERS 8
MERGERS & ACQUISITIONS 9
Mergers and Acquisitions – Overview 9
Mergers and Acquisitions – Deal reports 10
CORPORATE VENTURING 30
Corporate Venturing – Deal reports 30
PARTNERSHIP 42
Partnership – Deal reports 42
CAPITAL RAISING 48
Capital Raising – Overview 48
Capital Raising – Deal reports 49
DIVESTMENTS 57
Divestments – Overview 57
Divestments – Deal reports 58
PRIVATE EQUITY & OWNERSHIP 106
Private Equity and Ownership – Deal reports 106
APPENDIX 112
Contact Us 112
About MarketLine Financial Deals Database 112
Deal Definition and Methodology 114
About MarketLine 121

List of Tables
Table 1: ICICI Bank Limited M&A volume and value trend (2014-YTD2018)
Table 2: ICICI Bank Limited M&A activity by geography (2014-YTD2018)
Table 3: ICICI Bank Limited capital raising volume and value trend (2014-YTD2018)
Table 4: ICICI Bank Limited capital raising by deal type (2014-YTD2018)
Table 5: ICICI Bank Limited divestments volume and value trend (2014-YTD2018)
Table 6: ICICI Bank Limited divestments activity by geography (2014-YTD2018)

List of Figures
Figure 1: ICICI Bank Limited M&A volume and value trend (2014-YTD2018)
Figure 2: ICICI Bank Limited M&A activity by geography (2014-YTD2018)
Figure 3: ICICI Bank Limited capital raising volume and value trend (2014-YTD2018)
Figure 4: ICICI Bank Limited capital raising by deal type (2014-YTD2018)
Figure 5: ICICI Bank Limited divestments volume and value trend (2014-YTD2018)
Figure 6: ICICI Bank Limited divestments by geography (2014-YTD2018)

★海外企業調査レポート[ICICI Bank Ltd:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Pennon Group Plc (PNN):企業の財務・戦略的SWOT分析
    Pennon Group Plc (PNN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Novartis AG:企業のM&A・事業提携・投資動向
    Novartis AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Novartis AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Stena AB:企業の戦略的SWOT分析
    Stena AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Sichuan Kelun Pharmaceutical Co Ltd (002422):医療機器:M&Aディール及び事業提携情報
    Summary Sichuan Kelun Pharmaceutical Co., Ltd. (Kelun) is engaged in manufacturing and distribution of IV Solutions. The company’s products portfolio includes glucose injection, sodium chloride injection, glucose and sodium chloride injection, ringer’s injection, lactated ringer’s injection, compoun …
  • Instrumentation Laboratory Company-医療機器分野:企業M&A・提携分析
    Summary Instrumentation Laboratory Company (IL), a subsidiary of Werfen Life Group, is a medical device company with focus on in vitro diagnostics (IVD) devices. The company develops, manufactures, and distributes IVD instruments, related reagents and controls for hospitals and clinical laboratories …
  • AK Transneft (TRNFP):石油・ガス:M&Aディール及び事業提携情報
    Summary AK Transneft (Transneft) is a midstream oil and gas pipeline company that specializes in the transportation of crude oil and refined petroleum products. The company transports oil and oil products through trunk pipelines in the Russian Federation and outside. It carries out preventive mainte …
  • Assam Company India Ltd (ASSAMCO):企業の財務・戦略的SWOT分析
    Assam Company India Ltd (ASSAMCO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Yokogawa Electric Corp (6841):企業の財務・戦略的SWOT分析
    Yokogawa Electric Corp (6841) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • ASIT Biotech SA (ASIT):企業の財務・戦略的SWOT分析
    Summary ASIT Biotech SA (ASIT Biotech), formerly BioTech Tools SA is a clinical stage biopharmaceutical company that develops in-vitro and in-vivo biotech tools. The company develops and commercializes immunotherapy medicines for respiratory and food allergies using ASIT plus technology platform. It …
  • Aspen Pharmacare Holdings Ltd (APN):製薬・医療:M&Aディール及び事業提携情報
    Summary Aspen Pharmacare Holdings Ltd (Aspen) is a specialty and generic pharmaceuticals company that provides pharmaceutical drugs for a range of acute and chronic conditions. The company focuses on thrombosis, anesthetics and high potency and cytotoxics therapeutic categories. It also manufactures …
  • Jindal Power Ltd:電力:M&Aディール及び事業提携情報
    Summary Jindal Power Ltd (JPL) a subsidiary of Jindal Steel & Power Ltd, is a power generation company that builds and operates power plants. The company offers implementation, operation and planning of thermal power, hydroelectric and renewable energy power plants. Its hydroelectric projects includ …
  • Les Laboratoires Servier SAS:企業の戦略的SWOT分析
    Les Laboratoires Servier SAS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • moksha8 Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Moksha8 Pharmaceuticals Inc (Moksha8) is a specialty pharmaceutical company that offers therapeutic products. The company manufactures and commercializes products for the treatment of critical diseases. It provides vilazodone HCI for depressive disorder. Moksha8 commercialize a portfolio of …
  • Havas SA:企業の戦略・SWOT・財務分析
    Havas SA - Strategy, SWOT and Corporate Finance Report Summary Havas SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Miraca Holdings Inc (4544):製薬・医療:M&Aディール及び事業提携情報
    Summary Miraca Holdings Inc (Miraca Holdings) is a holding company that operates through its business segments such as clinical laboratory testing, in vitro diagnostics and healthcare segment. The company develops, manufactures and sells diagnostic products that are used in medical field for early d …
  • Miromatrix Medical Inc:製品パイプライン分析
    Summary Miromatrix Medical Inc (Miromatrix Medical) is a life science company that develops regenerative medicines. The company offers MIRODERM biologic wound matrix, MIROMESH biologic matrix, liver function restoration, kidney products, diabetes treatment and cortical strut. It creates biological r …
  • Royal BAM Group nv:戦略・SWOT・企業財務分析
    Royal BAM Group nv - Strategy, SWOT and Corporate Finance Report Summary Royal BAM Group nv - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Wawa Inc:企業の戦略・SWOT・財務分析
    Wawa Inc - Strategy, SWOT and Corporate Finance Report Summary Wawa Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Sasa Polyester Sanayi AS (SASA):企業の財務・戦略的SWOT分析
    Summary Sasa Polyester Sanayi AS (Sasa), formerly Advansa Sasa Polyester Sanayi AS, is a chemical company that produces filament yarns, polyester staple fibers, polyester-based and specialty polymers. The company offers products such as polyester elastomers, dimethyl terephthalate, advanite pbt solu …
  • NKT AS (NKT):企業の財務・戦略的SWOT分析
    NKT AS (NKT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆